Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Conference Paper
Full Text
Duke Authors
- Gasparetto, Cristina
- Horwitz, Mitchell Eric
- Kang, Yubin
- Li, Zhiguo
- Sarantopoulos, Stefanie
- Sung, Anthony D
Cited Authors
- Green, MMB; Horwitz, ME; Kang, Y; Chao, NJ; Long, GD; Rizzieri, D; Gasparetto, C; Sung, AD; Sarantopoulos, S; Li, Z; Corbet, K; Riggan-Stuelke, E; Sullivan, K; Wilson, B; Chhabra, S; Costa, LV; Mims, A; Stuart, R
Published Date
- February 2015
Published In
Volume / Issue
- 21 / 2
Start / End Page
- S31 - S32
Published By
International Standard Serial Number (ISSN)
- 1083-8791
Digital Object Identifier (DOI)
- 10.1016/j.bbmt.2014.11.024